Applied Filter(s) Clear Filter


Type:

Industry:

Therapy Area: Gastrointestinal Disorders

Category:

Short Bowel Syndrome Market

Report ID: PNPH1169 Industry: Pharma & Biotech Therapy Area: Gastrointestinal Disorders

Short Bowel Syndrome (SBS) is a group of problems related to poor absorption of nutrients. The main cause of SBS is surgery to remove a portion of the small intestine. This surgery can treat intestinal diseases, injuries, and birth defects. Some people are born with an abnormally short small intestine, significant damage, and poor motility, which can cause short bowel syndrome. Presently, there is no cure for SBS and the treatment is targeted toward symptoms. In a few cases, SBS can be life-threatening but usually, the disease can be managed through effective medication.

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.